Nuvectis Pharma, Inc. Common Stock (NASDAQ: NVCT) last traded at $20.36, down 3.60% on the session. The quote above updates while this page is open; the figures below are drawn from Nuvectis Pharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Nuvectis Pharma, Inc. Common Stock trades on NASDAQ under the ticker NVCT. Its market capitalisation is $663.36 million.
Valuation measures for Nuvectis Pharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $663.36M |
|---|---|
| Enterprise value | $654.49M |
| Price / book | 73.04 |
| Beta | 0.92 |
Trailing-twelve-month figures tagged in Nuvectis Pharma, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$27.85M |
| Return on equity | -306.61% |
|---|
| Cash | $22.16M |
|---|
Range and volume for NVCT over the past 52 weeks.
| 52-week high | $29.28 |
|---|---|
| 52-week low | $5.55 |
| Volume | 11.5K |
| Average volume | 211.2K |
| Previous close | $21.12 |
Dividend history for Nuvectis Pharma, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
Invest a chosen dollar amount in Nuvectis Pharma, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NVCT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.